Search research articles
Contact Us
Filters
Showing results (21-30 of 63) with videos related to
Page
of 7
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
April 17, 2016
Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis
Rocco Totaro, C Di Carmine, A Splendiani, et al.
Multiple Sclerosis International
|
August 13, 2015
Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study
Rocco Totaro, Caterina Di Carmine, Gianfranco Costantino, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
November 18, 2020
Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study results
Ruggero Capra, Vincenzo Brescia Morra, Massimiliano Mirabella, et al.
Frontiers in Neurology
|
July 5, 2024
Staged magnetic resonance-guided focused ultrasound thalamotomy for the treatment of bilateral essential tremor and Parkinson's disease related tremor: a systematic review and critical appraisal of current knowledge
Simone Cesarano, Gennaro Saporito, Patrizia Sucapane, et al.
Frontiers in Neurology
|
May 10, 2021
Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing-Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study)
Diego Centonze, Roberta Fantozzi, Fabio Buttari, et al.
Current Neuropharmacology
|
September 16, 2024
Disease-Modifying Symptomatic Treatment (DMST) Potential of Cannabinoids in Patients with Multiple Sclerosis
Antonio Bruno, Pietro Annovazzi, Marinella Clerico, et al.
Current Neuropharmacology
|
September 24, 2024
Disease-Modifying Symptomatic Treatment (DMST): The Potential Role of Vortioxetine in the Treatment of Depression in Patients with Multiple Sclerosis
Ettore Dolcetti, Pietro Annovazzi, Marinella Clerico, et al.
Journal of Neurology
|
September 16, 2023
Intravenous or subcutaneous natalizumab in patients with relapsing-remitting multiple sclerosis: investigation on efficiency and savings-the EASIER study
Massimo Filippi, Luigi Grimaldi, Antonella Conte, et al.
Frontiers in Neurology
|
July 2, 2024
Cognitive safety of focused ultrasound thalamotomy for tremor: 1-year follow-up results of the COGNIFUS part 2 study
Gennaro Saporito, Patrizia Sucapane, Federico Bruno, et al.
Frontiers in Neurology
|
October 10, 2024
Gender disparity in access to advanced therapies for patients with Parkinson's disease: a retrospective real-word study
Giuseppe Maccarrone, Gennaro Saporito, Patrizia Sucapane, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 63) with videos related to
Sort By:
Page
of 7
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
April 17, 2016
Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis
Rocco Totaro, C Di Carmine, A Splendiani, et al.
Multiple Sclerosis International
|
August 13, 2015
Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study
Rocco Totaro, Caterina Di Carmine, Gianfranco Costantino, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
November 18, 2020
Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study results
Ruggero Capra, Vincenzo Brescia Morra, Massimiliano Mirabella, et al.
Frontiers in Neurology
|
July 5, 2024
Staged magnetic resonance-guided focused ultrasound thalamotomy for the treatment of bilateral essential tremor and Parkinson's disease related tremor: a systematic review and critical appraisal of current knowledge
Simone Cesarano, Gennaro Saporito, Patrizia Sucapane, et al.
Frontiers in Neurology
|
May 10, 2021
Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing-Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study)
Diego Centonze, Roberta Fantozzi, Fabio Buttari, et al.
Current Neuropharmacology
|
September 16, 2024
Disease-Modifying Symptomatic Treatment (DMST) Potential of Cannabinoids in Patients with Multiple Sclerosis
Antonio Bruno, Pietro Annovazzi, Marinella Clerico, et al.
Current Neuropharmacology
|
September 24, 2024
Disease-Modifying Symptomatic Treatment (DMST): The Potential Role of Vortioxetine in the Treatment of Depression in Patients with Multiple Sclerosis
Ettore Dolcetti, Pietro Annovazzi, Marinella Clerico, et al.
Journal of Neurology
|
September 16, 2023
Intravenous or subcutaneous natalizumab in patients with relapsing-remitting multiple sclerosis: investigation on efficiency and savings-the EASIER study
Massimo Filippi, Luigi Grimaldi, Antonella Conte, et al.
Frontiers in Neurology
|
July 2, 2024
Cognitive safety of focused ultrasound thalamotomy for tremor: 1-year follow-up results of the COGNIFUS part 2 study
Gennaro Saporito, Patrizia Sucapane, Federico Bruno, et al.
Frontiers in Neurology
|
October 10, 2024
Gender disparity in access to advanced therapies for patients with Parkinson's disease: a retrospective real-word study
Giuseppe Maccarrone, Gennaro Saporito, Patrizia Sucapane, et al.
Page
of 7